Cancerous disease modifying antibodies

Details for Australian Patent Application No. 2006275261 (hide)

Owner Arius Research, Inc.

Inventors Hahn, Susan E.; Young, David S.F.; Cechetto, Lisa M.

Agent Davies Collison Cave

Pub. Number AU-A-2006275261

PCT Pub. Number WO2007/014460

Priority 60/704,647 02.08.05 US

Filing date 1 August 2006

Wipo publication date 8 February 2007

International Classifications

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/12 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

C12Q 1/04 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Determining presence or kind of micro-organism

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

24 April 2008 PCT application entered the National Phase

  PCT publication WO2007/014460 Priority application(s): WO2007/014460

21 May 2009 Assignment before Grant

  Arius Research, Inc. The application has been assigned to F.Hoffmann-La Roche AG

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006275263-EP4 receptor agonist, compositions and methods thereof

2006275260-Cancerous disease modifying antibodies